Literature DB >> 15303004

OCTN2 mutation (R254X) found in Saudi Arabian kindred: recurrent mutation or ancient founder mutation?

A-M Lamhonwah1, R Onizuka, S E Olpin, F Muntoni, I Tein.   

Abstract

The truncating R254X mutation in the OCTN2 gene results in defective high-affinity carnitine transport and has been previously described as a founder mutation in the Chinese population. We now report a Saudi Arabian kindred with this same mutation, suggesting that it may be a recurrent mutation or a very ancient founder mutation. Western blot analysis of skin fibroblast lysates from the proband with our specific anti-murine OCTN2 antibody revealed the absence of the OCTN2 protein.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15303004     DOI: 10.1023/B:BOLI.0000037339.25821.87

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  4 in total

1.  A third human carnitine/organic cation transporter (OCTN3) as a candidate for the 5q31 Crohn's disease locus (IBD5).

Authors:  Anne-Marie Lamhonwah; Jennifer Skaug; Stephen W Scherer; Ingrid Tein
Journal:  Biochem Biophys Res Commun       Date:  2003-01-31       Impact factor: 3.575

2.  A founder mutation (R254X) of SLC22A5 (OCTN2) in Chinese primary carnitine deficiency patients.

Authors:  Nelson L S Tang; W L Hwu; Rachel T Chan; L K Law; L M Fung; W M Zhang
Journal:  Hum Mutat       Date:  2002-09       Impact factor: 4.878

3.  Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2.

Authors:  I Tamai; R Ohashi; J Nezu; H Yabuuchi; A Oku; M Shimane; Y Sai; A Tsuji
Journal:  J Biol Chem       Date:  1998-08-07       Impact factor: 5.157

4.  Novel OCTN2 mutations: no genotype-phenotype correlations: early carnitine therapy prevents cardiomyopathy.

Authors:  Anne-Marie Lamhonwah; Simon E Olpin; Rodney J Pollitt; Christine Vianey-Saban; Priscille Divry; Nathalie Guffon; Guy T N Besley; Russell Onizuka; Linda J De Meirleir; Ljerka Cvitanovic-Sojat; Ivo Baric; Carlo Dionisi-Vici; Ksenija Fumic; Miljenka Maradin; Ingrid Tein
Journal:  Am J Med Genet       Date:  2002-08-15
  4 in total
  5 in total

1.  Identification of mutations and evaluation of cardiomyopathy in Turkish patients with primary carnitine deficiency.

Authors:  M Kilic; R K Ozgül; T Coşkun; D Yücel; M Karaca; H S Sivri; A Tokatli; M Sahin; T Karagöz; A Dursun
Journal:  JIMD Rep       Date:  2011-09-22

2.  Importance of molecular diagnosis in the accurate diagnosis of systemic carnitine deficiency.

Authors:  Toshiaki Hitomi; Norio Matsuura; Yosuke Shigematsu; Yoshiyuki Okano; Eri Shinozaki; Masahiko Kawai; Hatasu Kobayashi; Kouji H Harada; Akio Koizumi
Journal:  J Genet       Date:  2015-03       Impact factor: 1.166

3.  Primary Carnitine deficiency in the Faroe Islands: health and cardiac status in 76 adult patients diagnosed by screening.

Authors:  Jan Rasmussen; Lars Køber; Allan M Lund; Olav W Nielsen
Journal:  J Inherit Metab Dis       Date:  2013-08-21       Impact factor: 4.982

4.  Twin Brothers with Carnitine Membrane Transporter Deficiency: A Case Study.

Authors:  Elham Hashemi Dehkordi; Payam Sobhani; Nabiolah Asadpour; Mahin Hashemipour; Neda Mostofizadeh
Journal:  Adv Biomed Res       Date:  2018-07-02

5.  A case of atypical systemic primary carnitine deficiency in Saudi Arabia.

Authors:  Abdulrahman Alghamdi; Hani Almalki; Aiman Shawli; Rahaf Waggass; Fahad Hakami
Journal:  Pediatr Rep       Date:  2018-06-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.